Nukkleus (NUKK) director granted 10,000 shares on Form 4

Nukkleus Inc. (NUKK) reported that a company director acquired additional common stock through an equity award.

Rhea-AI Filing Summary

Nukkleus Inc. (NUKK) reported that a company director acquired additional common stock through an equity award. On 11/13/2025, the reporting person received 10,000 shares of Nukkleus common stock at a price of $0 per share under the company’s 2025 Equity Incentive Plan in consideration of services rendered to the company. After this transaction, the director beneficially owns 20,000 shares of Nukkleus common stock held directly.

Insider Trade Summary

Grant/Award: 10,000 shares

Grant/Award 1 txn

Insider Yeganeh Reuven

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, $0.0001 par value per share	10,000	$0.00	$0.00

Holdings After Transaction: Common Stock, $0.0001 par value per share — 20,000 shares (Direct)

Footnotes (1)

1. F1. The shares were issued to the reporting person under the Company's 2025 Equity Incentive Plan in consideration of services rendered to the Company.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Nukkleus Inc. (NUKK) report in this Form 4?

A Nukkleus Inc. director reported acquiring 10,000 shares of common stock on 11/13/2025 through an equity award.

At what price were the 10,000 NUKK shares acquired by the director?

The 10,000 shares of Nukkleus common stock were acquired at a price of $0 per share as an equity award.

How many Nukkleus (NUKK) shares does the director own after this transaction?

Following the reported transaction, the director beneficially owns 20,000 shares of Nukkleus common stock held directly.

Under which plan were the new NUKK shares granted to the director?

The shares were issued under Nukkleus Inc.’s 2025 Equity Incentive Plan in consideration of services rendered to the company.

Was this Nukkleus (NUKK) Form 4 filed for one or multiple reporting persons?

The Form 4 was indicated as filed by one reporting person, who serves as a director of Nukkleus Inc.

What is the relationship of the reporting person to Nukkleus Inc. (NUKK)?

The reporting person is a director of Nukkleus Inc., as indicated in the filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/20/2025 - 02:27 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Yeganeh Reuven

(Last) (First) (Middle)

C/O NUKKLEUS INC.

575 FIFTH AVENUE, 14TH FLOOR

(Street)

NEW YORK NY 10017

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Nukkleus Inc. [ NUKK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/13/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $0.0001 par value per share	11/13/2025		A		10,000	A	$0(1)	20,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares were issued to the reporting person under the Company's 2025 Equity Incentive Plan in consideration of services rendered to the Company.

	/s/ Reuven Yeganeh	11/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.